or its pharmaceutically acceptable salt with antagonist activity to corticotrophin release factor (CRF). In formula (I) X means heteroaryl chosen of pyrazolyl and imidazolyl optionally substituted with (C1-C6)alkyl, haloid or phenyl; Y means -NRaRb where Ra means hydrogen, and Rb means phenyl optionally substituted with (C1-C6)alkyl or haloid; Z means (C1-C6)alkyl; and R1 means hydrogen, (C1-C6)alkyl or haloid.;EFFECT: compounds can find application in treatment, eg of neurodegenerative diseases, neuropsychiatric disorders and stresses.;19 cl, 1 dwg, 2 tbl, 4 ex"/>
公开/公告号RU2377241C2
专利类型
公开/公告日2009-12-27
原文格式PDF
申请/专利权人 F.KHOFFMANN-LJA ROSH AG;
申请/专利号RU20060122416
申请日2004-11-16
分类号C07D403/04;A61K31/506;A61P25/28;A61P25/24;A61P25/18;
国家 RU
入库时间 2022-08-21 18:29:52